Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancer.
Dahut WL; Gulley JL; Arlen PM; Liu Y; Fedenko KM; Steinberg SM; Wright JJ; Parnes H; Chen CC; Jones E; Parker CE; Linehan WM; Figg WD; Journal Of Clinical Oncology: Official Journal Of The American Society Of Clinical Oncology, 2004, vol. 22, issue 13, p 2532, ISSN 0732183x. ISBN 0732183x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef